Order Article Reprints

Tulaeva I, Lehmann F, Goldmann N, Dubovets A, Trifonova D, Tulaev M, Cornelius C, Weber M, Focke-Tejkl M, Karaulov A, et al. The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines. Vaccines. 2024; 12(10):1123. https://doi.org/10.3390/vaccines12101123

Tulaeva, Inna, Felix Lehmann, Nora Goldmann, Alexandra Dubovets, Daria Trifonova, Mikhail Tulaev, Carolin Cornelius, Milena Weber, Margarete Focke-Tejkl, Alexander Karaulov, and et al. 2024. "The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines" Vaccines 12, no. 10: 1123. https://doi.org/10.3390/vaccines12101123

Tulaeva, I., Lehmann, F., Goldmann, N., Dubovets, A., Trifonova, D., Tulaev, M., Cornelius, C., Weber, M., Focke-Tejkl, M., Karaulov, A., Henning, R., Springer, D. N., Wiedermann, U., Glebe, D., & Valenta, R. (2024). The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines. Vaccines, 12(10), 1123. https://doi.org/10.3390/vaccines12101123